This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1A Kilaru , EB Blancaflor , BJ Venables , (2007) The N-acylethanolamine-mediated regulatory pathway in plants. Chem Biodivers 4, 1933–1955.
2Y Okamoto , J Wang , J Morishita , (2007) Biosynthetic pathways of the endocannabinoid anandamide. Chem Biodivers 4, 1842–1857.
3F Borrelli & AA Izzo (2009) Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Best Prac Res Clin Endocrinol Metab 23, 33–49.
4SPH Alexander & DA Kendall (2007) The complications of promiscuity: endocannabinoid action and metabolism. Br J Pharmacol 152, 602–623.
5V Di Marzo , T Bisogno & L De Petrocellis (2007) Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem Biol 14, 741–756.
6G Re , R Barbero , A Miolo , (2007) Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. Vet J 173, 21–30.
7L Hoareau , M Buyse , F Festy , (2009) Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. Obesity 17, 431–438.
8C Thabuis , D Tissot-Favre , JB Bezelgues , (2008) Biological functions and metabolism of oleoylethanolamide. Lipids 43, 887–894.
9GJ Schwartz , J Fu , G Astarita , (2008) The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8, 281–288.
11M Dalle Carbonare , E Del Giudice , A Stecca , (2008) A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story. J Neuroendocrinol 20, 26–34.
12S Burstein (2008) The elmiric acids: biologically active anandamide analogs. Neuropharmacology 55, 1259–1264.
13SH Burstein & RB Zurier (2009) Cannabinoids, endocannabinoids, and related analogs in inflammation. AAPS J 11, 109–119.
14PC Calder (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77, 327–335.
15PC Calder (2008) The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 79, 101–108.
17WS Harris & D Bulchandani (2006) Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 17, 387–393.
18GL Russo (2009) Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 77, 937–946.
19A Artmann , G Petersen , LI Hellgren , (2008) Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781, 200–212.
20A Berger , G Crozier , T Bisogno , (2001) Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci U S A 98, 6402–6406.
21T Bisogno , I Delton-Vandenbroucke , A Milone , (1999) Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamide in bovine retina. Arch Biochem Biophys 370, 300–307.
22K Eckardt , H Sell , A Taube , (2009) Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia 52, 664–674.
23MG Balvers , KC Verhoeckx , P Plastina , (2010) Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties. Biochim Biophys Acta 1801, 1107–1114.
24P Plastina , J Meijerink , J-P Vincken , (2009) Selective synthesis of unsaturated N-acylethanolamines by lipase-catalyzed N-acylation of ethanolamine with unsaturated fatty acids. Lett Org Chem 6, 444–447.
25E Lupinacci , J Meijerink , JP Vincken , (2009) Xanthohumol from hop (Humulus lupulus L.) is an efficient inhibitor of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha release in LPS-stimulated RAW264.7 mouse macrophages and U937 human monocytes. J Agric Food Chem 57, 7274–7281.
26LC Green , DA Wagner & J Glogowski (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126, 131–138.
27PC Calder (2009) Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 91, 791–795.
29JC Umhau , W Zhou , RE Carson , (2009) Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res 50, 1259–1268.
31P Dallaire , K Bellmann , M Laplante , (2008) Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. Diabetes 57, 1999–2011.
32PJ Kuhlencordt , J Chen , F Han , (2001) Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 103, 3099–3104.
33P Ponnuswamy , E Ostermeier , A Schrottle , (2009) Oxidative stress and compartment of gene expression determine proatherosclerotic effects of inducible nitric oxide synthase. Am J Pathol 174, 2400–2410.
34WS Jobgen , SK Fried , WJ Fu , (2006) Regulatory role for the arginine–nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem 17, 571–588.
35C Bogdan (2001) Nitric oxide and the immune response. Nat Immunol 2, 907–916.
36SM Weldon , AC Mullen , CE Loscher , (2007) Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem 18, 250–258.
37YX Sun , K Tsuboi , LY Zhao , (2005) Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Biochim Biophys Acta 1736, 211–220.
38L Boring , J Gosling , M Cleary , (1998) Decreased lesion formation in CCR2− / − mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894–897.
39L Gu , Y Okada , SK Clinton , (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2, 275–281.
40H Kanda , S Tateya , Y Tamori , (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116, 1494–1505.
41S Tateya , Y Tamori , T Kawaguchi , (2010) An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice. Endocrinology 151, 971–979.
43TD Mickleborough , SL Tecklenburg , GS Montgomery , (2009) Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin Nutr 28, 71–77.
44Y Shi & JJ Pestka (2009) Mechanisms for suppression of interleukin-6 expression in peritoneal macrophages from docosahexaenoic acid-fed mice. J Nutr Biochem 20, 358–368.
45G Schmitz & J Ecker (2008) The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 47, 147–155.
46CN Serhan , N Chiang & TE Van Dyke (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8, 349–361.
47DF Woodward , RWC Carling , CL Cornell , (2008) The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol Ther 120, 71–80.
48PJ White & A Marette (2006) Is omega-3 key to unlocking inflammation in obesity? Diabetologia 49, 1999–2001.
49S Watanabe , M Doshi & T Hamazaki (2003) n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot Essent Fatty Acids 69, 51–59.
50B Batetta , M Griinari , G Carta , (2009) Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr 139, 1495–1501.
51T Bisogno , D Melck , L De Petrocellis , (1998) Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 248, 515–522.
52S Banni & V Di Marzo (2010) Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. Mol Nutr Food Res 54, 82–92.
53SM Grundy (2006) Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 5, 295–309.
54GS Hotamisligil (2006) Inflammation and metabolic disorders. Nature 444, 860–867.
56SE Shoelson , J Lee & AB Goldfine (2006) Inflammation and insulin resistance. J Clin Invest 116, 1793–1801.
58M Fujimoto , N Shimizu , K Kunii , (2005) A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54, 1340–1348.
59S Engeli , J Janke , K Gorzelniak , (2004) Regulation of the nitric oxide system in human adipose tissue. J Lipid Res 45, 1640–1648.
60H Sugita , M Kaneki , E Tokunaga , (2002) Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282, E386–E394.